Brief: U.S. FDA Approves Celltrion Inc's Omlyclo, Biosimilar To Xolair
07/03/2025 18:06
March 7 (Reuters) - U.S. FDA: U.S. FDA APPROVES CELLTRION INC'S OMLYCLO, BIOSIMILAR TO XOLAIR - WEBSITE Further company coverage: 068270.KS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares